The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Tips for Myositis Management

Tips for Myositis Management

March 19, 2013 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Case 2

A 38-year-old man had seen a skin rash on his hand, along with arthralgia, in August of 2004. By November, he’d developed a cough and breathlessness. Those symptoms had worsened within a few months, and he’d developed mild muscle weakness, too.

You Might Also Like
  • New Tools for Myositis Diagnosis, Classification & Management
  • Myositis AutoantibodiesTriggered by Statins
  • Tips for Interdisciplinary Pain Management in Older Patients
Also By This Author
  • Evaluation & Treatment of Systemic Sclerosis-ILD in the New Decade

Tests found his CK levels were normal. He was also found to have interstitial lung disease (ILD), which was rapidly progressing, and the man was positive for SSA/anti-Ro antibodies.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

He was found to be major histocompatibility complex (MHC) class I positive on muscle fibers in the muscle biopsy investigated by immunohistochemistry, as well as positive for anti-MDA5, an antibody recently found to be associated with dermatomyositis, which was determined to be the patient’s diagnosis.

The Tips

Dr. Lundberg said that a normal CK and normal histopathology do not exclude dermatomyositis, and that an MRI and testing for myositis-specific antibodies can be helpful.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

More specifically, this patient could be classified as having clinically amyopathic dermatomyositis, with a skin rash typical of dermatomyositis, but combined with rapidly progressing ILD and the presence of anti-MDA5 antibodies.

She also said a link between ILD and myositis has been increasingly recognized, with ILD in 60% to 70% of dermatomyositis and polymyositis cases—and, in fact, it might be the first clinical symptom of myositis. Anti-MDA5 antibodies may be associated with a rapidly progressive ILD.

Another similar subgroup is antisynthetase syndrome, characterized by ILD, myositis, arthritis, fever, Raynaud’s disease, and an association with the HLA-DRB1 allele. It can be found in dermatomyositis and polymyositis. Eight antibodies are linked with this subgroups—the most common is anti-Jo-1.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Case 3

At about age 44, a man was diagnosed with polymyositis. He had developed atrial fibrillation from the time he was 35; by 44, he had arm and leg weakness, along with myalgia. A muscle biopsy had found degenerating and regenerating fibers but no inflammatory cell infiltrates, and he was MHC class I positive in his muscle fibers.

He was treated, but at age 57, he still had profound muscle weakness, and had developed swallowing problems and atrophy of the hamstrings, but a muscle biopsy from the quadriceps is normal.

The man was then found to be antinuclear antibody negative but anti–signal recognition particle positive and was diagnosed with immune-mediated necrotizing myopathy, a disorder characterized by cardiac involvement and treatment-resistant myositis.

The Tips

Dr. Lundberg said it’s important to be aware of cancer-associated myositis. No particular kind of cancer is overrepresented, and there are no specific clinical features to look for. But, she said that if a dermatomyositis is treatment resistant, an underlying malignancy should be considered. There is an association with the anti–TIF1 gamma antibody, which is not yet commercially available.1

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Soft Tissue Pain Tagged With: dermatomyositis, Myopathy, myositis

You Might Also Like:
  • New Tools for Myositis Diagnosis, Classification & Management
  • Myositis AutoantibodiesTriggered by Statins
  • Tips for Interdisciplinary Pain Management in Older Patients
  • Promising Avenues in Myositis: Research Targets Disease Specificity

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)